Spindiag GmbH seeks strategic investors for 15-min point-of-care multiplex PCR system amid preliminary insolvency proceedings
Spindiag GmbH, a start-up company in the field of molecular in-vitro diagnostics, has announced the opening of preliminary insolvency proceedings as a result of challenging market conditions caused by the rapid decline of COVID-19 testing. The company remains operational and Mehr